Medicine News and Research

RSS

Black patients more likely to be chemically sedated at the EDs than their white counterparts

Black patients presenting at Emergency Departments (EDs) across the country with psychiatric complaints are 63 percent more likely to be chemically sedated than their white counterparts.

7 Apr 2023

UW researchers engineer stem cells that do not generate dangerous arrhythmias

Researchers at the University of Washington School of Medicine in Seattle have engineered stem cells that do not generate dangerous arrhythmias, a complication that has to date thwarted efforts to develop stem-cell therapies for injured hearts.

7 Apr 2023

General Awareness Gaps and Affordability Concerns Revealed with State of Colorectal Cancer Awareness Report

From BGI Genomics 7 Apr 2023

Epidural electrical stimulation stabilizes blood pressure in patients suffering from spinal cord injury

An implant that delivers electrical stimulation to a select group of spinal neurons can treat dangerously low blood pressure in people with spinal cord injuries, addressing an often "invisible" consequence of paralysis.

7 Apr 2023

Specific proteins in the blood may help predict which COVID-19 patients may become critically ill

Researchers at Washington University School of Medicine in St. Louis have identified specific proteins that may help predict which COVID-19 patients may need to be placed on ventilators to breathe and which are most likely to die of the virus.

6 Apr 2023

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.

6 Apr 2023

Improving cancer awareness among the rural American Indian communities

Phyllis Nassi, MSW, associate director of research and science, special populations, directs the American Indian program at Huntsman Cancer Institute and recently received the 2023 American Association for Cancer Research Distinguished Public Service Award for Exceptional Leadership in Cancer Advocacy.

6 Apr 2023

Case study shows how COVID-19 breached the placenta and caused brain damage in the baby

Researchers at UHealth-;the University of Miami Health System and the University of Miami Miller School of Medicine have shown that, in two cases, COVID-19 infection breached the placenta and caused brain damage in the newborn.

6 Apr 2023

Just one extra scan could save mothers-to-be and their babies from complications

Adding a third routine scan at the end of pregnancy can slash the number of unexpected breech births by 70% and the risks of the baby being born with severe health complications, according to research led by doctors at St George's, University of London, and published in PLOS Medicine.

6 Apr 2023

The economic burden of RSV infections in low and middle-income countries

Researchers discuss the cost-of-illness associated with RSV infections among children in low and middle-income countries.

6 Apr 2023

Injectable microtissue shows promise to improve neuromuscular recovery after peripheral nerve injuries

Researchers engineered the first injectable microtissue containing motor and sensory neurons encased in protective tissue, called tissue engineered neuromuscular interfaces (TE-NMIs).

6 Apr 2023

Study identifies disparities among patients receiving advanced pulmonary support

Some adults with severe respiratory illness, including women, those with public insurance, and people with fewer financial resources, may be less likely to receive an advanced form of life support known as extracorporeal membrane oxygenation (ECMO).

6 Apr 2023

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Combinatorial biomarker predicts response to immunotherapy in kidney cancer patients

The number of immune cells in and around kidney tumors, the amount of dead cancer tissue, and mutations to a tumor suppressor gene called PBRM1 form a biomarker signature that can predict — before treatment begins — how well patients with kidney cancer will respond to immunotherapy, according to new research directed by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Study reveals potential for digital technology to improve patients' asthma control

A new international study led by RCSI University of Medicine and Health Sciences has revealed significant potential for digital technology to improve asthma control for patients.

6 Apr 2023

New machine learning model estimates optimal treatment timing for sepsis

A new machine learning model that estimates optimal treatment timing for sepsis could pave the way for support tools that help physicians personalize treatment decisions at the patient bedside, researchers say.

6 Apr 2023

Fasting diet could be the key to reducing the risk of type 2 diabetes

A fasting diet which focuses on eating early in the day could be the key to reducing the risk of developing type 2 diabetes.

6 Apr 2023

Analyzing DNA changes in the blood can improve prediction of type 2 diabetes risk

Analyzing changes to DNA in the blood can improve the ability to predict a person's risk of developing type 2 diabetes within a decade.

6 Apr 2023

Researchers discover and characterize a novel protein involved in tumor suppression mechanism

Understanding how cancer develops is critical for designing effective, personalized cancer therapies. Researchers have known for years that cancer begins with mutations in certain types of genes.

6 Apr 2023

Intramuscular injection of TXA may be a potential alternative to reduce obstetric bleeding

Intramuscular administration of tranexamic acid (TXA), a drug used to target severe bleeding after childbirth, is safe and quickly reaches therapeutic concentrations in pregnant women, according to a study involving researchers from the London School of Hygiene & Tropical Medicine.

6 Apr 2023

Medicine News and Research

Black patients more likely to be chemically sedated at the EDs than their white counterparts

UW researchers engineer stem cells that do not generate dangerous arrhythmias

General Awareness Gaps and Affordability Concerns Revealed with State of Colorectal Cancer Awareness Report

Epidural electrical stimulation stabilizes blood pressure in patients suffering from spinal cord injury

Specific proteins in the blood may help predict which COVID-19 patients may become critically ill

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

Improving cancer awareness among the rural American Indian communities

Case study shows how COVID-19 breached the placenta and caused brain damage in the baby

Just one extra scan could save mothers-to-be and their babies from complications

The economic burden of RSV infections in low and middle-income countries

Injectable microtissue shows promise to improve neuromuscular recovery after peripheral nerve injuries

Study identifies disparities among patients receiving advanced pulmonary support

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

Combinatorial biomarker predicts response to immunotherapy in kidney cancer patients

Study reveals potential for digital technology to improve patients' asthma control

New machine learning model estimates optimal treatment timing for sepsis

Fasting diet could be the key to reducing the risk of type 2 diabetes

Analyzing DNA changes in the blood can improve prediction of type 2 diabetes risk

Researchers discover and characterize a novel protein involved in tumor suppression mechanism

Intramuscular injection of TXA may be a potential alternative to reduce obstetric bleeding

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News